| Literature DB >> 33062832 |
Huri Seval Gönderen Çakmak1, Doğan Uncu2.
Abstract
OBJECTIVE: The aim of this study was to explore the relationship between health literacy and self-report medication adherence of Turkish cancer patients receiving oral chemotherapy.Entities:
Keywords: Cancer; health literacy; medication adherence; oral agents
Year: 2020 PMID: 33062832 PMCID: PMC7529023 DOI: 10.4103/apjon.apjon_30_20
Source DB: PubMed Journal: Asia Pac J Oncol Nurs ISSN: 2347-5625
Demographic characteristics of the patients (n=100)
| Characteristics | % | |
|---|---|---|
| Age, mean (SD) | 60.59±8.75 | |
| Gender | ||
| Male | 43 | 43 |
| Female | 57 | 57 |
| Educational status | ||
| Literate | 14 | 14 |
| Primary school | 35 | 35 |
| Middle school | 32 | 32 |
| High school | 16 | 16 |
| University | 3 | 3 |
| Diagnosis of the disease | ||
| Breast cancer | 51 | 51 |
| Colon cancer | 19 | 19 |
| Gastric cancer | 13 | 13 |
| Brain cancer | 11 | 11 |
| Rectum cancer | 6 | 6 |
| OC drug | ||
| Capecitabine | 36 | 36 |
| Tamoksifen | 25 | 25 |
| Sunitinibe | 13 | 13 |
| Temozolomide | 11 | 11 |
| Letrazol | 9 | 9 |
| Regorafenib | 6 | 6 |
OC: oral chemotherapy
The scores of the patients on the scales
| Scale | Mean±SD | Min/Max | Median |
|---|---|---|---|
| Health Literacy Scale | 12.39±1.51 | 10/16 | 13 |
| Oral Chemotherapy Adherence Scale | 73.25±6.18 | 60/86 | 75 |
Descriptive statistics
| Characteristics | Oral Chemotherapy Adherence Scale Average | Health Literacy Scale Average | ||
|---|---|---|---|---|
| Gender | ||||
| Male | 76.13 | <0.05* | 13.48 | <0.05* |
| Female | 71.07 | 11.56 | ||
| Educational status | ||||
| Literate | 72.96 | <0.05** | 12.34 | <0.05** |
| Primary school | 73.25 | 12.39 | ||
| Middle school | 72.93 | 12.37 | ||
| High school | 72.81 | 12.66 | ||
| University | 76.43 | 13.52 | ||
| Diagnosis of the disease | ||||
| Breast cancer | 73.20 | <0.05** | 12.39 | <0.05** |
| Colon cancer | 72,78 | 12.48 | ||
| Gastric cancer | 72,97 | 12.75 | ||
| Brain cancer | 76,13 | 13.48 | ||
| Rectum cancer | 69,68 | 12.35 | ||
| OC drug | ||||
| Capecitabine | 73.20 | <0.05** | 12.39 | <0.05** |
| Tamoksifen | 72.54 | 12.72 | ||
| Sunitinibe | 72.97 | 12.75 | ||
| Temozolomide | 75.85 | 13.40 | ||
| Letrazol | 72.70 | 12.64 | ||
| Regorafenib | 70.04 | 12.39 |
*The student’s test; **One-way ANOVA; OC: oral chemotherapy